US$ 25.04
bpc-157 human clinical trial 2023 2024 2025 and the gut–brain axis: emerging links between cytoprotection and neuroregeneration BPC-157 & The Gut-Brain Axis:
Description
The peptide has also demonstrated interactions with the dopaminergic and serotonergic systems, with studies showing that BPC-157 can modulate the effects of dopamine-related agents in animal models and counteract some behavioural and neurochemical consequences of both dopamine agonists and antagonists (Sikiric et al., 2010)

Repeated freeze-thaw cycles following reconstitution should be avoided to preserve structural integrity

The biological role and timing of the CSD pathway is still unknown

doi: 10.1038/nature14363 17 AllamanIBelangerMMagistrettiPJ

doi: 10.1359/JBMR.0301263
